A new drug for prostate cancer shows a minimum of side effects, as it turned out in the course of research. Besides, it really extends the life of patients with terminal cancer.
Recently, America has lost one of the most exciting actors in Hollywood, the brilliant Dennis Hopper. The creator of "Easy Rider," died of Prostate Cancer . The disease is found to have Hopper lately her stage , after cancer It has spread to other organs. Doctors have not been able to do anything.
Now, in these patients there is hope - new Vaccine Provenge That in April this year was approved by the US government for use as a treatment the last stages of prostate cancer . The vaccine Provenge Primarily addressed to those patients who did not help hormonal therapy.
As the first results of the vaccine, it is observed at least side effects . The advantage Vaccine Provenge in the fact that the drug helps patients with metastatic disease, by acting on them less destructive than chemotherapy. In addition, the vaccine increases the life expectancy of patients with the last stage of cancer On average, four and a half months. This figure can not be called great, but some patients Provenge added two or three years of life.
Such data are contained in three studies, which consists of four stages, which covered 904 patients with the last stage of prostate cancer . Some of the patients received the Provenge vaccine And some placebo. Established definitions - extends the life of the vaccine, has fewer side effects than chemotherapy and improves quality of life, which is also important.
Treatment and prevention
Go back to the main page
No comments:
Post a Comment